Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Market Gems:Stocks w/Strong Earnings and High Tech. Rank -- Ignore unavailable to you. Want to Upgrade?

To: McHugh who wrote (22240)	1/15/1999 11:07:00 PM
From: VLAD	Respond to of 120523

VVUS The company that makes MUSE is said to be very close to signing on a domestic partner to market MUSE in the United States. MUSE has an excellent safety profile and currently more and more concerns are being raised in regards to the safety of its competitor Viagra. Rumor has it that they should announce a partner by their January 28th conference call. Both Lilly and Astra/Zeneca are believed to be the most likely candidates to market MUSE. IMO if an announcement is made we can easily see a run from 3 to double digits. The stock still has 7.5 million shares held short on a float of 29 million.